Botanix Pharmaceuticals (BOT.AX) Earnings Analysis
Botanix Pharmaceuticals (BOT.AX) next reports earnings on 2026-08-28, consensus EPS -0.01 AUD. Last quarter (2026-02-26) it missed with EPS -0.0169 AUD vs -0.01 AUD est (-69%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -0.49.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BOT.AX next report earnings?
| Next earnings date | 2026-08-28 |
|---|---|
| Consensus EPS estimate | -0.01 AUD |
| Revenue estimate | 0.02B |
BOT.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -0.0169 AUD | -0.01 AUD | -69% | Miss |
| 2025-02-26 | -0.017 AUD | 0.001 AUD | -1800% | Miss |
| 2024-08-30 | -0.00537 AUD | n/a | n/a | n/a |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
BOT.AX valuation and analyst view
| Trailing P/E | -0.49 |
|---|---|
| Trailing EPS | -0.04516 AUD |
| Price / book | 0.84 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Botanix Pharmaceuticals (BOT.AX)'s next earnings date?
Botanix Pharmaceuticals is next scheduled to report on 2026-08-28, with a consensus EPS estimate of -0.01 AUD and revenue estimate of 0.02B.
Did BOT.AX beat earnings last quarter?
In its 2026-02-26 report, BOT.AX posted EPS of -0.0169 AUD versus a -0.01 AUD estimate — a miss of 69%.
What is BOT.AX's earnings track record?
Over the last 2 reported quarters with consensus data, BOT.AX beat estimates 0 times (0%).
What is BOT.AX's current P/E ratio and EPS?
BOT.AX trades at a trailing P/E of -0.49 on trailing EPS of -0.045159519738698174 AUD.
What do analysts rate BOT.AX?
BOT.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.